Table 5.
Adverse Event | BCLC 0–A 52 Patients (Grade 2/3) |
BCLC B–D 19 Patients (Grade 2/3) |
Total Number (Grade 2/3) |
---|---|---|---|
Acute toxicity | |||
Hepatobiliary enzyme | 0/0 | 1/0 | 1/0 |
Cytopenia | 0/0 | 0/0 | 0/0 |
Dermatitis | 2/0 | 2/0 | 4/0 |
Decrease in Child–Pugh score ≥ 2 | 0 | 0 | 0 |
Radiation pneumonitis1 | 0/0 | 0/0 | 0/0 |
Late toxicity | |||
Hepatobiliary enzyme | 0/0 | 0/0 | 0/0 |
Cytopenia | 0/0 | 0/0 | 0/0 |
Dermatitis | 0/0 | 0/1 | 0/1 |
Decrease in Child–Pugh score ≥ 2 | 1 2 | 3 2 | 4 2 |
Radiation pneumonitis 1 | 0/0 | 0/0 | 0/0 |
Soft-tissue inflammation | 1/0 | 0/0 | 1/0 |
Rib fracture | 1/0 | 0/0 | 1/0 |
1 Pneumonitis occurring within the irradiation field within and after 3 months was defined as acute and late radiation pneumonitis, respectively; 2 potentially due to original cirrhosis and infection.